Dr Reddy`s gets tentative approval for Ziprasidone Hydrochloride

Posted on: December 31, 2008 at 4:04 pm | 32 views




Dr Reddy`s Laboratories has received tentative approval from the US Food and Drug Administration (USFDA) to market Ziprasidone Hydrochloride capsules, in the strengths of 20 mg, 40 mg, 60 mg and 80 mg.

Ziprasidone Hydrochloride is prescribed to treat schizophrenia. It is also used for the short-term treatment of mania associated with bipolar disorder.

Dr Reddy`s is a vertically integrated, global pharmaceutical company with proven research capabilities and presence across the pharmaceutical value chain.

-IRIS.

  • Share/Save/Bookmark




Tags:, , , , , , , ,

Related Post :


  • Search

  • Investment Books

  • Smart Investment